Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Todd Neale

November 05, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Daily News

Higher CV Mortality Among More Socially Vulnerable US Adults

Yael L. Maxwell

October 20, 2021

News Daily News

Big Impact Anticipated With HFpEF Expansion of Sacubitril/Valsartan Label

Todd Neale

September 20, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Daily News

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Yael L. Maxwell

February 18, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

Presentation TVT 2017

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

Presenter: Mark Reisman, Gregg W. Stone, Clyde W. Yancy

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

L.A. McKeown

May 24, 2016

News Industry News

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

December 08, 2015

Advertisement

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

TCTMD’s Top 10 Most Popular Stories for May 2022

Higher CV Mortality Among More Socially Vulnerable US Adults

Big Impact Anticipated With HFpEF Expansion of Sacubitril/Valsartan Label

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

The Biggest News of 2019: TCTMD’s Top 10

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

TCTMD’s Top 10 Most Popular Stories for January 2018

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content